抗Hepatitis B Virus X Protein [X36C]抗体 | Anti-Hepatitis B Virus X Protein [X36C] antibody

• 特長
• 価格
• DATA IMAGES
• 製品情報
• APPLICATION
• PROPERTIES
• TARGET

特長

• 高品質の抗体です。
• 幅広い研究分野に関連する抗体を取り揃えています。
• 使用されたアプリケーションや動物種などの情報が充実しています。
• 多数の論文で使用実績がある信頼性の高い抗体です。

目次に戻る

価格

目次に戻る

DATA IMAGES

Non-transfected (–) and transfected (+) Huh7 whole cell extracts (25 μg) were separated by 12% SDS-PAGE, and the membrane was blotted with Hepatitis B Virus X Protein antibody [X36C] (GTX22741) diluted at 1:1000.

目次に戻る

製品情報

Host	Mouse
Clonality	Monoclonal
Clone Name	X36C
Isotype	IgG1
Application	WB, ICC/IF, IP, ELISA, ChIP assay, IHC
Reactivity	Hepatitis B virus

目次に戻る

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.

Application	Dilution
WB	1 μg/ml
ICC/IF	Assay dependent
IP	Assay dependent
ELISA	Assay dependent
ChIP assay	Assay dependent
IHC	Assay dependent

Not tested in other applications.

Specificity/Sensitivity	This antibody is not capable of immunoprecipitating HBx complexed with HBx interacting protein (XIP).

目次に戻る

PROPERTIES

Form	Liquid
Buffer	PBS, 0.05% sodium azide
Storage	Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Concentration	1 mg/ml (Please refer to the vial label for the specific concentration.)
Antigen Species	Hepatitis B virus
Immunogen	Baculovirus expressed recombinant HBx.
Purification	Purified by HPLC
Conjugation	Unconjugated
Note	For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

目次に戻る

TARGET

Synonyms

Hepatitis B Virus X antigen , HBV X antigen

Background

The hepatitis B virus is an important cause of acute and chronic liver disease. It is also the most common form of parenterally transmitted viral hepatitis. The virus is estimated to affect some 350 million people worldwide. Immunization against hepatitis B is an important component of preventative medicine and is offered to all children in approximately 30 countries. Hepatitis B virus (HBV) belongs to the Hepadnaviridae family and infection with HBV is usually more serious than infection with hepatitis A virus. In some individuals the infection is not cleared and followed by persistent intracellular viral carriage that can lead to the development of hepatocelular carcinomas. There are currently 400 million HBV carriers worldwide making HBV one of the most common human pathogens.

目次に戻る